Dr. Weizhong LAN, a member of IMI, shared the history and future of myopia prevention and control frame lens. He believed that different degrees of myopia should not wear lenses with the same design and the same defocus amount, by detecting the relative diopter around the retina and drawing the retinal refractive topography, it has been confirmed that the retinal refractive topography of different human eyes is different, that is, thousands of people have thousands of faces. With the continuous listing of Thondar's MRT equipment and similar products, The era of personalized correction guided by retinal refractive topography has come!

【About Dr. Weizhong Lan】

Dr. Weizhong Lan is a full professor in Central South University, China and the vice director of Aier Institute of Optometry and Vision Science, Aier EYE Hospital Group. He finished his clinical training as an Ophthalmologist in Zhongshan Ophthalmic Center (China) and achieved his M.D / Ph.D of Neuroscience in University of Tuebingen (Germany). His main interest is to understand the pathogenesis of myopia and to develop new approaches to correct and control myopia. He has led more than 10 clinical trials investigating the efficacy and safety of anti-myopia interventions. He is also the co-inventor of the first wearable device to collect myopia-related environmental factors in the world, called Clouclip®. Recently he and his team just won the bid of hosting the International Myopia Conference (IMC) 2023 in China. （From IMI website）

【About IMI】

The International Myopia Institute was formed following the WHO-BHVI meeting on myopia and high myopia in 2015, due to the need to address the increasing levels of myopia and high myopia worldwide that can lead to potentially sight threatening complications for an individual, and the massive global burden associated with lost productivity.

The IMI are a global group of experts who have come together to discuss, debate and make available the latest evidence based recommendations in classifications, patient management, and research, in the form of the IMI white papers. The IMI white papers and clinical summaries are made freely available in many world languages so that the evidence can be disseminated to all corners of the world and to those that would benefit the most – practitioners, governments, policy makers, educators and the general public.

Our mission is to advance research, patient management and education in myopia to prevent future vision impairment and blindness associated with increasing myopia.  We aim to do this by bringing together, but not limited to scientists, clinicians, policy makers, government and educators into the field of myopia to stimulate collaboration and sharing of knowledge.

（From IMI website）